Overview

Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

Status:
Completed

Trial end date:
2021-10-19

Target enrollment:

Participant gender:

Summary

Safety and Efficacy Study of BRIMOCHOL™ vs. BRIMOCHOL™ F vs. Carbachol Monotherapy Topical Ophthalmic Solutions in Subjects with Emmetropic Phakic and Pseudophakic Presbyopia

Phase:

Phase 2

Details

Lead Sponsor:

Visus Therapeutics

Treatments:

Brimonidine Tartrate
Carbachol